Business ❯Pharmaceutical Industry ❯Acquisitions
2024 Outlook J&J and Ambrx Deal Pharma Industry Outlook
The acquisition aims to boost J&J's oncology portfolio with Ambrx's promising antibody-drug conjugates technology.
